Singapore markets close in 4 hours 2 minutes

Tianjin Zhong Xin Pharmaceutical Group Corporation Limited (T14.SI)

SES - SES Delayed Price. Currency in USD
Add to watchlist
1.02000.0000 (0.00%)
As of 05:04PM SGT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 1.93B
Enterprise value 1.54B
Trailing P/E 7.00
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/sales (ttm)0.76
Price/book (mrq)0.81
Enterprise value/revenue 0.22
Enterprise value/EBITDA 1.77

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 30.99%
S&P500 52-week change 3-2.90%
52-week high 31.3200
52-week low 30.9500
50-day moving average 31.0498
200-day moving average 31.1094

Share statistics

Avg vol (3-month) 3203.13k
Avg vol (10-day) 3160.62k
Shares outstanding 5200M
Implied shares outstanding 6N/A
Float 8419.58M
% held by insiders 10.00%
% held by institutions 10.46%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.05
Forward annual dividend yield 44.51%
Trailing annual dividend rate 30.50
Trailing annual dividend yield 349.02%
5-year average dividend yield 43.87
Payout ratio 430.38%
Dividend date 3N/A
Ex-dividend date 415 Jun 2021
Last split factor 22:1
Last split date 330 Jun 2010

Financial highlights

Currency in CNY.

Fiscal year

Fiscal year ends 31 Dec 2021
Most-recent quarter (mrq)31 Mar 2022

Profitability

Profit margin 10.84%
Operating margin (ttm)8.33%

Management effectiveness

Return on assets (ttm)4.01%
Return on equity (ttm)12.00%

Income statement

Revenue (ttm)6.97B
Revenue per share (ttm)9.04
Quarterly revenue growth (yoy)3.40%
Gross profit (ttm)2.75B
EBITDA 693.86M
Net income avi to common (ttm)755.8M
Diluted EPS (ttm)0.1440
Quarterly earnings growth (yoy)-6.30%

Balance sheet

Total cash (mrq)2.69B
Total cash per share (mrq)3.51
Total debt (mrq)30.4M
Total debt/equity (mrq)0.45
Current ratio (mrq)2.65
Book value per share (mrq)8.55

Cash flow statement

Operating cash flow (ttm)818.26M
Levered free cash flow (ttm)418.06M